-+ 0.00%
-+ 0.00%
-+ 0.00%

Ensysce Biosciences Q1 EPS $(1.39) Beats $(3.02) Estimate, Sales $1.32M Up From $305.72K YoY

Benzinga·05/13/2025 20:39:17
Listen to the news
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(1.39) per share which beat the analyst consensus estimate of $(3.02) by 53.97 percent. This is a 83.07 percent increase over losses of $(8.21) per share from the same period last year. The company reported $1.32 million in sales this quarter. This is a 331.69 percent increase over sales of $305.72 thousand the same period last year.